Poster 23
- Jun 12, 2023
- 1 min read
Tralokinumab Treatment in Patients with Atopic Dermatitis and Moderate-to-Severe Hand Involvement: Results from the 32-Week Phase 3b ADHAND Trial
Benjamin Ehst,1 Richard B. Warren,H. Chih-ho Hong, Dong Hun Lee, Andrei Metelitsa, Sebastian Volc, Marie Tauber, Farzaneh Safavimanesh, Ann-Marie Tindberg, Linda Stein-Gold


